The Effects of Education Given to Primiparous Pregnant Women Who Have Fear of Childbirth According to Joyce Travelbee's Human-to-Human Relationship Model on Fear of Childbirth, Readiness for Childbirth and Acceptance of the Maternal Role
Launched by HASAN KALYONCU UNIVERSITY · Apr 25, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of education on first-time pregnant women who are afraid of childbirth. The goal is to see if providing information and support can help reduce their fear, improve their readiness for childbirth, and increase their acceptance of becoming a mother. The study will take place at Kilis Prof. Dr. Alaeddin Yavaşca State Hospital from March to July 2025.
To participate, women must be in their third trimester (between 28-40 weeks) and this must be their first pregnancy. They should also be experiencing a moderate to high level of fear about childbirth, as measured by a specific questionnaire. Participants will receive education and support during their visits to the hospital, and their feelings and experiences will be assessed before and after the program. This trial aims to provide valuable insights into how education can help ease fears and prepare women for childbirth, which is an important step in their journey to motherhood.
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria:1. The pregnant woman's first pregnancy. 2. A mid-level or above score on the Wijma Childbirth Expectation/Experience Scale Version A.
- • 3. The pregnant woman is between 28-40 weeks of gestation (third trimester). 4. The pregnant woman does not have a chronic health problem. 5. The pregnant woman has a single fetus. 6. The pregnant woman has not received infertility treatment. 7. The pregnant woman has not received a psychiatric diagnosis. 8. The pregnant woman does not have a high-risk pregnancy. 9. The pregnant woman's acceptance to participate in the study.
- • Exclusion Criteria:1. Not willing to participate in the study 2. Not speaking Turkish 3. Illiterate, having communication difficulties 4. Not meeting the study criteria
- • -
About Hasan Kalyoncu University
Hasan Kalyoncu University is a distinguished academic institution dedicated to advancing research and education in the health sciences. With a commitment to innovation and excellence, the university actively sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. By fostering collaboration among researchers, healthcare professionals, and industry partners, Hasan Kalyoncu University strives to contribute to the development of effective therapies and interventions, ultimately aiming to address pressing health challenges and promote public well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kilis, Merkez, Turkey
Patients applied
Trial Officials
Prof.Dr.Ümran SEVİL
Study Director
Hasan Kalyoncu University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported